Literature DB >> 12056915

Electrostatic and hydrophobic forces tether the proximal region of the angiotensin II receptor (AT1A) carboxyl terminus to anionic lipids.

Henriette Mozsolits1, Sharon Unabia, Ariani Ahmad, Craig J Morton, Walter G Thomas, Marie-Isabel Aguilar.   

Abstract

The carboxyl terminus of the type-1 angiotensin II receptor (AT(1A)) is a focal point for receptor activation and deactivation. Synthetic peptides corresponding to the membrane-proximal, first 20 amino acids of the carboxyl terminus adopt an alpha-helical conformation in organic solvents, suggesting that the secondary structure of this region may be sensitive to hydrophobic environments. Using surface plasmon resonance, immobilized lipid chromatography, and circular dichroism, we examined whether this positively charged, amphipathic alpha-helical region of the AT(1A) receptor can interact with lipid components in the cell membrane and thereby modulate local receptor attachment and structure. A synthetic peptide corresponding to the proximal region of the AT(1A) receptor carboxyl terminus (Leu(305) to Lys(325)) was shown by surface plasmon resonance to bind with high affinity to the negatively charged lipid, dimyristoyl L-alpha-phosphatidyl-DL-glycerol (DMPG), but poorly to the zwitterionic lipid, dimyristoyl L-alpha-phosphatidylcholine (DMPC). In contrast, a peptide analogue possessing substitutions at four lysine residues (corresponding to Lys(307,308,310,311)) displayed poor association with either lipid, indicating a crucial anionic component to the interaction. Circular dichroism analysis revealed that both the wild-type and substituted peptides possessed alpha-helical propensity in methanol and trifluoroethanol, while the wild-type peptide also adopted partially inserted helical structure in DMPG and DMPC liposomes. In contrast, the substituted peptide exhibited spectra that suggested the presence of beta-sheet and alpha-helical structure in both liposomes. Immobilized lipid chromatography was used to characterize the hydrophobic component of the membrane interaction, and the results demonstrated that hydrophobic and electrostatic interactions mediated the binding of the wild-type peptide but that the substituted peptide bound to the model membranes mainly via hydrophobic forces. We propose that, in intact AT(1A) receptors, the proximal carboxyl terminus associates with the cytoplasmic face of the cell membrane via a high-affinity, anionic phospholipid-specific tethering that serves to increase the amphipathic helicity of this region. Such associations may be important for receptor function and common for G protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12056915     DOI: 10.1021/bi0121813

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  Extramembranous Regions in G Protein-Coupled Receptors: Cinderella in Receptor Biology?

Authors:  Sreetama Pal; Amitabha Chattopadhyay
Journal:  J Membr Biol       Date:  2019-08-30       Impact factor: 1.843

Review 2.  Mechanisms of the anterograde trafficking of GPCRs: Regulation of AT1R transport by interacting proteins and motifs.

Authors:  Maoxiang Zhang; Guangyu Wu
Journal:  Traffic       Date:  2018-12-07       Impact factor: 6.215

3.  Recombinant cannabinoid type 2 receptor in liposome model activates g protein in response to anionic lipid constituents.

Authors:  Tomohiro Kimura; Alexei A Yeliseev; Krishna Vukoti; Steven D Rhodes; Kejun Cheng; Kenner C Rice; Klaus Gawrisch
Journal:  J Biol Chem       Date:  2011-12-01       Impact factor: 5.157

4.  Structure of the Angiotensin receptor revealed by serial femtosecond crystallography.

Authors:  Haitao Zhang; Hamiyet Unal; Cornelius Gati; Gye Won Han; Wei Liu; Nadia A Zatsepin; Daniel James; Dingjie Wang; Garrett Nelson; Uwe Weierstall; Michael R Sawaya; Qingping Xu; Marc Messerschmidt; Garth J Williams; Sébastien Boutet; Oleksandr M Yefanov; Thomas A White; Chong Wang; Andrii Ishchenko; Kalyan C Tirupula; Russell Desnoyer; Jesse Coe; Chelsie E Conrad; Petra Fromme; Raymond C Stevens; Vsevolod Katritch; Sadashiva S Karnik; Vadim Cherezov
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

5.  The membrane-binding properties of a class A amphipathic peptide.

Authors:  H Mozsolits; T-H Lee; A H A Clayton; W H Sawyer; M-I Aguilar
Journal:  Eur Biophys J       Date:  2003-07-18       Impact factor: 1.733

6.  A single mutation in helix 8 enhances the angiotensin II type 1a receptor transport and signaling.

Authors:  Shu Zhu; Maoxiang Zhang; Jason E Davis; William H Wu; Kristen Surrao; Hong Wang; Guangyu Wu
Journal:  Cell Signal       Date:  2015-09-02       Impact factor: 4.315

Review 7.  Membranes: a meeting point for lipids, proteins and therapies.

Authors:  Pablo V Escribá; José M González-Ros; Félix M Goñi; Paavo K J Kinnunen; Lászlo Vigh; Lissete Sánchez-Magraner; Asia M Fernández; Xavier Busquets; Ibolya Horváth; Gwendolyn Barceló-Coblijn
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

8.  Helix 8 of the angiotensin- II type 1A receptor interacts with phosphatidylinositol phosphates and modulates membrane insertion.

Authors:  Daniel J Hirst; Tzong-Hsien Lee; Leonard K Pattenden; Walter G Thomas; Marie-Isabel Aguilar
Journal:  Sci Rep       Date:  2015-06-30       Impact factor: 4.379

9.  In silico prediction of ARB resistance: A first step in creating personalized ARB therapy.

Authors:  Shane D Anderson; Asna Tabassum; Jae Kyung Yeon; Garima Sharma; Priscilla Santos; Tik Hang Soong; Yin Win Thu; Isaac Nies; Tomomi Kurita; Andrew Chandler; Abdelaziz Alsamarah; Rhye-Samuel Kanassatega; Yun L Luo; Wesley M Botello-Smith; Bradley T Andresen
Journal:  PLoS Comput Biol       Date:  2020-11-25       Impact factor: 4.475

10.  Real-time measurement of membrane conformational states induced by antimicrobial peptides: balance between recovery and lysis.

Authors:  Kristopher Hall; Tzong-Hsien Lee; Adam I Mechler; Marcus J Swann; Marie-Isabel Aguilar
Journal:  Sci Rep       Date:  2014-06-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.